Economy

Swiss parliament backs faster approval of pesticides

Parliament approves easier authorisation of pesticides

This content was published on Mar 5, 2026 Swiss parliament backs faster approval for some pesticides from neighboring countries.

Middle East war causes stock market losses

War & peace

Swiss stock market takes slight tumble as war in Middle East escalates

This content was published on Mar 2, 2026 The Swiss Market Index (SMI) did not fall quite as sharply in early trading Monday as its key European counterparts.

Agribusiness

Syngenta CEO: ‘No formal decision has been made on a potential IPO’

This content was published on Feb 28, 2026 Jeff Rowe, CEO of the Syngenta Group, headquartered in Switzerland, explains why being Chinese-owned is good for the company.

The Swiss are set to vote on the issue of GMO food

Agribusiness

Swiss anti-GMO initiative handed in at Bern

This content was published on Feb 27, 2026 Swiss anti-GMO initiative handed in with 137,000 signatures.

New treatments

Switzerland’s bitter-sweet news for Alzheimer’s patients

This content was published on Feb 27, 2026 Swissmedic was expected to approve two drugs for Alzheimer‘s disease. But it only approved one. What happened?

Food safety

Does infant formula have too many ingredients?

This content was published on Feb 26, 2026 Several European countries, including in Switzerland, have reported illnesses that may be linked to toxic contamination in infant formula.

There have been reports of hospitalisation of infants who were fed the recalled formula in France and Spain.

Food safety

Infant formula recall: Is trying to copy breastmilk increasing risk of contamination?

This content was published on Feb 25, 2026 A contaminated additive found naturally in breastmilk is responsible for the recent recall of infant formula worldwide.

The banking sector has been particularly affected by redundancies.

Pharma supply chains

Why unemployment in Switzerland is increasing more than elsewhere in Europe

This content was published on Feb 24, 2026 The number of people in Switzerland who are out of work increased for the second year in a row. This contrasts with the situation in the European Union.

Detail view of a thousand Swiss franc note

Assisted suicide

Switzerland no longer wants to foot the bill for ‘suicide tourism’

This content was published on Feb 21, 2026 In Switzerland, all deaths through assisted suicide must be followed by a medical and legal investigation. This entails considerable costs for the state.

Roche obtains FDA approval to treat a form of leukaemia

New treatments

FDA approves Roche leukaemia treatment

This content was published on Feb 20, 2026 Genentech obtains FDA approval for treatment for chronic lymphocytic leukaemia (CLL).

Page 7 of 36

First … 5 6 7 8 9 … Last

Economy

Popular Stories

Most Discussed

Economy

More

Swiss parliament backs faster approval of pesticides

More

Swiss stock market takes slight tumble as war in Middle East escalates

More

Syngenta CEO: ‘No formal decision has been made on a potential IPO’

More

Swiss anti-GMO initiative handed in at Bern

More

Switzerland’s bitter-sweet news for Alzheimer’s patients

More

Does infant formula have too many ingredients?

More

Infant formula recall: Is trying to copy breastmilk increasing risk of contamination?

More

Why unemployment in Switzerland is increasing more than elsewhere in Europe

More

Switzerland no longer wants to foot the bill for ‘suicide tourism’

More

FDA approves Roche leukaemia treatment

Popular Stories

Most Discussed